Fig. 4From: Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trialIsodose comparison of sRT and SOC RT on T2 image. Patient shown receiving sRT (Fig. 4) is the same as in Fig. 2 planned for fBT (Fig. 3). Isodoses: Blue 100%; Green 95%; Red 75%; Pink 60%; Yellow 45%Back to article page